← FDA Drug Approvals (Drugs@FDA)
POTASSIUM PHOSPHATES
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2026-03-12
Drug application
- FDA Application #
ANDA220373- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POTASSIUM PHOSPHATES
- Generic name
- POTASSIUM PHOSPHATES
- Active ingredients
- POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- CAPLIN
- Manufacturer
- Caplin Steriles Limited
- First approval
- 2026-03-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown